> 首页 > 产品 > 一抗 > 基因重组 > Anti-TNFRSF13C / BAFFR / CD268 Reference Antibody (ianalumab)

Anti-TNFRSF13C / BAFFR / CD268 Reference Antibody (ianalumab)

Recombinant Antibody

Anti-TNFRSF13C / BAFFR / CD268 Reference Antibody (ianalumab) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.
The purity of Anti-TNFRSF13C / BAFFR / CD268 Reference Antibody (ianalumab) is 100%, determined by SEC-HPLC.
Immobilized human GPA33 / A33, Fc Tag at 2 ug/mL can bind ianalumab, EC50=0.008489 ug/mL.

产品详情
实验流程

Product Information
Application Applications Legend: E=ELISA WB=Western Blotting IHC=Immunohistochemistry IHC-P=Immunohistochemistry (Paraffin) IP=Immunoprecipitation IF=Immunofluorescence IC=Immunochemistry ICC=Immunocytochemistry FC=Flow Cytometry DB=Dot Blot	Functional assay, Kinetics (SPR), Kinetics (BLI), FACS, E, FTA
Primary Accession	Q96RJ3
Reactivity	Human
Clonality	Monoclonal
Isotype	IgG1
Calculated MW	18864 Da

Additional Information
Target/Specificity	TNFRSF13C / BAFFR / CD268
Endotoxin	< 0.001EU/ µg,determined by LAL method.
Conjugation	Unconjugated
Expression system	CHO
Format	Purified monoclonal antibody supplied in PBS, pH6.0, without preservative.This antibody is purified through a protein A column.

For Research Use Only. Not For Use In Diagnostic Procedures.

Patent Notice: The variable region sequence of this antibody is derived from a published third-party patent. This product is manufactured independently as a Research Use Only (RUO) reagent and is not licensed, sponsored, or endorsed by the patent holder. It is intended solely for research purposes. Customers considering any commercial, diagnostic, or therapeutic use should independently evaluate freedom-to-operate with respect to relevant third-party patents.

Protein Information
Name	TNFRSF13C
Synonyms	BAFFR, BR3
Function	B-cell receptor specific for TNFSF13B/TALL1/BAFF/BLyS. Promotes the survival of mature B-cells and the B-cell response.
Cellular Location	Membrane; Single-pass type III membrane protein
Tissue Location	Highly expressed in spleen and lymph node, and in resting B-cells. Detected at lower levels in activated B-cells, resting CD4+ T-cells, in thymus and peripheral blood leukocytes

Research Areas

Application Protocols

Provided below are standard protocols that you may find useful for product applications.

Western Blot Protocol

Blocking Peptides Protocol

Dot Blot Protocol

Immunohistochemistry Protocol

Immunofluorescence Protocol

Immunoprecipitation Protocol

Flow Cytomety Protocol

Cell Culture Protocol